Foundry Partners LLC raised its position in shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 34.9% during the second quarter, Holdings Channel reports. The firm owned 39,693 shares of the software maker’s stock after buying an additional 10,275 shares during the period. Foundry Partners LLC’s holdings in Allscripts Healthcare Solutions were worth $506,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the stock. Thrivent Financial For Lutherans boosted its stake in Allscripts Healthcare Solutions by 255.4% in the first quarter. Thrivent Financial For Lutherans now owns 111,780 shares of the software maker’s stock worth $1,418,000 after buying an additional 80,330 shares during the period. Neuburgh Advisers LLC boosted its stake in Allscripts Healthcare Solutions by 4.1% in the first quarter. Neuburgh Advisers LLC now owns 12,070 shares of the software maker’s stock worth $153,000 after buying an additional 476 shares during the period. Canada Pension Plan Investment Board boosted its stake in Allscripts Healthcare Solutions by 12.0% in the first quarter. Canada Pension Plan Investment Board now owns 82,200 shares of the software maker’s stock worth $1,042,000 after buying an additional 8,800 shares during the period. OppenheimerFunds Inc. boosted its stake in Allscripts Healthcare Solutions by 9.4% in the first quarter. OppenheimerFunds Inc. now owns 31,445 shares of the software maker’s stock worth $399,000 after buying an additional 2,701 shares during the period. Finally, Dalton Greiner Hartman Maher & Co. acquired a new stake in Allscripts Healthcare Solutions during the second quarter worth approximately $1,276,000.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) opened at 12.85 on Friday. The firm’s 50-day moving average price is $12.51 and its 200-day moving average price is $12.21. The firm’s market cap is $2.32 billion. Allscripts Healthcare Solutions, Inc. has a 1-year low of $9.80 and a 1-year high of $13.70.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings results on Thursday, August 3rd. The software maker reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.15 by $0.04. The company had revenue of $426.10 million for the quarter, compared to analysts’ expectations of $424.94 million. Allscripts Healthcare Solutions had a positive return on equity of 5.97% and a negative net margin of 11.54%. The business’s quarterly revenue was up 10.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.14 EPS. On average, equities research analysts anticipate that Allscripts Healthcare Solutions, Inc. will post $0.62 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Allscripts Healthcare Solutions, Inc. (MDRX) Position Raised by Foundry Partners LLC” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at https://www.watchlistnews.com/allscripts-healthcare-solutions-inc-mdrx-position-raised-by-foundry-partners-llc/1506252.html.

MDRX has been the subject of a number of recent analyst reports. BidaskClub upgraded Allscripts Healthcare Solutions from a “strong sell” rating to a “sell” rating in a research report on Tuesday, June 13th. Maxim Group restated a “buy” rating and issued a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. Piper Jaffray Companies restated a “hold” rating and issued a $14.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Friday, July 21st. Morgan Stanley lifted their price target on Allscripts Healthcare Solutions from $11.00 to $12.00 and gave the stock an “underweight” rating in a research note on Monday, August 7th. Finally, Zacks Investment Research raised Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $14.59.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.